Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
| dc.contributor.author | Rico, Stephanie | pt_BR |
| dc.contributor.author | Sher, Ifat | pt_BR |
| dc.contributor.author | Lavinsky, Fábio | pt_BR |
| dc.contributor.author | Lavinsky, Daniel | pt_BR |
| dc.contributor.author | Rotenstreich, Ygal | pt_BR |
| dc.date.accessioned | 2025-03-27T06:41:55Z | pt_BR |
| dc.date.issued | 2024 | pt_BR |
| dc.identifier.issn | 2451-9936 | pt_BR |
| dc.identifier.uri | http://hdl.handle.net/10183/289107 | pt_BR |
| dc.description.abstract | Purpose The purpose of this case report is to outline the management of a 41-year-old female with pathological myopia and type II choroidal neovascularization (CNV) diagnosed by optical coherence tomography angiography (OCT-A) angio-B mode. Observations The early detection of CNV with OCT-A angio-B mode and treatment with intra-vitreous injections of Bevacizumab contributed to the amelioration of her vision to 20/20, a better visual acuity than she had prior to treatment. Conclusions and importance This case report suggests that an OCT-A scan may reveal the initial formation of abnormal vasculature before pathological changes are evident in structural OCT, allowing for prompt treatment and resolution in patients with myopic CNV. | en |
| dc.format.mimetype | application/pdf | pt_BR |
| dc.language.iso | eng | pt_BR |
| dc.relation.ispartof | American journal of ophthalmology case reports. [Atlanta]. Vol. 34 (June 2024), 102041, 5 p. | pt_BR |
| dc.rights | Open Access | en |
| dc.subject | Miopia | pt_BR |
| dc.subject | Choroidal neovascularization | en |
| dc.subject | Myopia | en |
| dc.subject | Bevacizumab | pt_BR |
| dc.subject | Optical coherence tomography angiography | en |
| dc.subject | Tomografia de coerência óptica | pt_BR |
| dc.subject | Bevacizumab | en |
| dc.subject | Angio-B mode | en |
| dc.title | Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab | pt_BR |
| dc.type | Artigo de periódico | pt_BR |
| dc.identifier.nrb | 001243883 | pt_BR |
| dc.type.origin | Estrangeiro | pt_BR |
Este item está licenciado na Creative Commons License
-
Artigos de Periódicos (44406)Ciências da Saúde (12177)

